Tom Frieden
Showing 1–3 of 3 transcripts.
- Milken Institute1h 19m
Prevention and Wellness: The Keys to a Healthier, More Prosperous Society
Paul Erring, Mike Milken, Peter Attia, Dean Ornish, Troy, Lynn Goldman, Tom Frieden
The 17th Annual Global Conference convened 3,500 stakeholders to advocate for shifting the healthcare paradigm from reactive treatment to evidence-based prevention, highlighting that lifestyle interventions can reverse severe conditions like heart disease and cellular aging. Speakers detailed economic imperatives for this shift, noting that comprehensive behavioral changes have slashed individual healthcare costs by up to 400% while major retailers and the Centers for Medicare and Medicaid Services are aligning policies to reimburse these programs. The event concluded with an urgent call to realign financial incentives away from the current "sick care" model, projecting that such systemic changes could prevent the first generation in a century from being less healthy than their predecessors and save trillions in productivity losses.
- Milken Institute57 min
The 2014 Atlanta Summit - - Government, Industry and a Healthier Future: A Leadership Forum
Mike Milken, Tom Frieden, Vince, Representative Kinston, Representative Bishop, Sue Siegel, Bob Hugin, Steve Knapp, Jack
Industry leaders from GE and Beckman Coulter, joined by Congressional representatives Sanford Bishop and Mike Kingston, convened to align public-private strategies for leveraging CDC data in pandemic preparedness and chronic disease management. Discussions highlighted a critical shift toward subscription-based surveillance funding and point-of-care diagnostic innovations, driven by the economic imperative to address the projected $1 trillion annual cost of chronic illnesses. Participants concluded by urging a reframing of public health as a driver of economic competitiveness, calling for rigorous data monetization to secure congressional support for prevention initiatives.
- Milken Institute1h 11m
Lunch Panel: A Cure for What Ails Us: Celebrating the Impact of Science (updated II)
Nancy Brown, Francis Collins, Thomas Frieden, Andrew von Eschenbach, Michael Milken, Mike Milken, Tom Frieden, Andy Van Eschenbach, Jack Andreyka
A comprehensive analysis of global bioscience reveals a dramatic increase in life expectancy and major breakthroughs in disease eradication, such as the near-elimination of polio and HIV management through programs like PEPFAR. Despite these successes, the sector faces a critical funding crisis where declining NIH grant success rates and inflation-adjusted budget cuts threaten the pipeline of young researchers and the translation of genetic discoveries into new treatments. Strategic initiatives like the Brain Initiative, precision medicine efforts, and the shift toward prevention are now essential to address rising chronic disease burdens and sustain the bioscience industry as a primary driver of US economic growth.